← Back to headlines
Barclays Lowers Price Target on Hims & Hers Health (HIMS)
Barclays has lowered its price target on Hims & Hers Health, Inc. (HIMS) to $25 while keeping an Overweight rating.
5 Mar, 20:28 — 5 Mar, 20:28
Sources
Showing 1 of 1 sources
